dfabd3c-ae5f-5ad4-a0eb-7ba027bf553f
at
ClaimsKG
http://data.gesis.org/claimskg/creative_work/9dfabd3c-ae5f-5ad4-a0eb-7ba027bf553f
Property
Value
?:
author
claimskg:
creative_work_author/6c51f611-0bba-5026-bde1-0cc50ce09658
?:
citation
<
https://www.senate.mo.gov/state-sen-cindy-olaughlin-opposes-prescription-monitoring-program-heres-why?
>
?:
datePublished
2019-02-14
(xsd:date)
is
?:
itemReviewed
of
claimskg:
claim_review/b5551f24-cf08-5da1-a789-14def3c88748
?:
keywords
claimskg:
keyword/0a31ab75-1430-5f03-a96c-736a9cef52ed
claimskg:
keyword/3037d7dc-a210-5c55-bd93-b23e47f1b265
claimskg:
keyword/3ed5450e-ba62-585a-b31e-76cbfb74781f
claimskg:
keyword/caa706b8-69a8-5b2f-8b28-07c4d658630e
claimskg:
keyword/fcf112bc-d42d-5334-82c1-acbb9deb7447
?:
mentions
claimskg:
mention/6d7add55-aabd-5d98-bfa4-8d7b4b4187c8
claimskg:
mention/b0b9c3c3-6957-58fe-9829-f6ebea0b8344
claimskg:
mention/d72622ff-7e99-5fca-81bf-503a139b5e37
?:
text
When comparing state by state, the data clearly demonstrates that over 20 other states with (Prescription Drug Monitoring Programs) are still substantially worse off than Missouri in terms of curbing the effects of opioid abuse.
(en)
rdf:
type
<
http://schema.org/CreativeWork
>